Short answer
DoxyPEP means taking doxycycline after sex to reduce the chance of certain bacterial STIs. CDC says healthcare providers should discuss doxyPEP with gay, bisexual, and other men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the past 12 months. DoxyPEP does not replace regular testing, does not treat an STI that is already present, and does not prevent HIV, herpes, hepatitis, or every STI.
What doxyPEP is and is not
| Question | CDC-aligned answer | Testing caveat |
|---|---|---|
| What is it? | Doxycycline post-exposure prophylaxis, taken after sex when prescribed by a clinician. | It should sit inside a broader sexual health plan, not replace screening. |
| Which STIs? | CDC describes reduced chances of syphilis, chlamydia, and, in some studies, gonorrhea. | Testing still matters because doxyPEP is not 100% protective. |
| Which STIs are not covered? | It does not prevent HIV, herpes, hepatitis, HPV, mpox, or all infections transmitted during sex. | Ask about HIV testing, PrEP versus PEP timing, PrEP labs and follow-up, hepatitis testing and vaccines, and symptom-based evaluation. |
| Who should discuss it? | CDC focuses on MSM and transgender women with a bacterial STI in the past 12 months; some others may discuss it through shared decision-making, but data are limited for several populations. | Your testing history helps a clinician decide whether the conversation fits you. |
| Does it treat an STI? | No. CDC says the prevention dose is not strong enough to treat an STI if you have one. | Symptoms or positive results need diagnosis and treatment guidance. |
Testing before starting matters
CDC clinical guidance says initial care for doxyPEP should include screening and treatment as indicated for STIs. That means gonorrhea and chlamydia nucleic acid amplification testing at exposed body sites and syphilis blood testing. People without HIV should also discuss HIV screening, HIV PrEP, or HIV PEP when relevant; the timing is different, so see the PrEP vs PEP testing timelines guide.
Follow-up testing is part of doxyPEP care
CDC says follow-up visits should happen every 3 to 6 months. At those visits, clinicians can screen for gonorrhea and chlamydia at sites of exposure, screen for syphilis, reassess HIV prevention needs, discuss side effects, and decide whether doxyPEP is still appropriate.
Body-site testing still counts
DoxyPEP does not make urine-only screening enough. If oral or anal sex is part of your exposure history, ask about throat or rectal testing for chlamydia and gonorrhea. For more detail, see the extragenital STI testing guide and the chlamydia and gonorrhea testing guide.
What to ask a clinician or clinic
- Does my STI history make doxyPEP worth discussing under current CDC guidance?
- Before starting, should I be tested for chlamydia, gonorrhea, syphilis, HIV, hepatitis B, or hepatitis C?
- Which body sites should be tested based on oral, anal, vaginal, or front-hole sex?
- How often should I return for STI and HIV testing?
- What side effects, drug interactions, pregnancy considerations, or medication timing issues should I know about?
- If I have symptoms or a partner tests positive, should I test, treat, or both?
If you test positive while using doxyPEP
A positive result should lead to standard STI treatment guidance, partner notification, and retesting plans when recommended. Do not assume taking doxyPEP covers treatment. For a practical checklist, see the positive STI result next steps guide; for timing, see the STI retesting after treatment guide.
Where to ask about it
CDC points people to clinics that can provide confidential or low-cost testing and prescribe doxycycline when appropriate. Local health departments, sexual health clinics, LGBTQ-focused clinics, HIV PrEP clinics, and some primary care or telehealth clinicians may be able to help. For access options, see the free and low-cost STI testing guide.
If you are also using or considering HIV PrEP, the lab schedule is different from doxyPEP follow-up. See the PrEP labs and STI testing follow-up guide. If you are building a recurring testing agreement with multiple partners, see the open relationship and multiple-partner testing guide.
FAQ
Does doxyPEP replace regular STI testing?
No. CDC says people using doxyPEP should still have regular HIV and STI screening, and follow-up visits every 3 to 6 months are part of ongoing care.
What infections does doxyPEP help prevent?
CDC describes doxyPEP as a strategy that can help some people reduce the chances of syphilis, chlamydia, and, in some studies, gonorrhea. It does not prevent HIV, herpes, hepatitis, or all STIs.
How soon after sex should doxyPEP be taken?
CDC guidance says doxycycline should be taken as soon as possible, within 72 hours after sex, and not more than once in a 24-hour period.
Who should discuss doxyPEP with a clinician?
CDC especially recommends discussion for gay, bisexual, and other men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the past 12 months. Other people may discuss it through shared decision-making, but evidence is more limited.
What testing happens before starting doxyPEP?
CDC says initial care should include screening and treatment as indicated for STIs, usually including gonorrhea and chlamydia testing at exposed sites, syphilis blood testing, and HIV screening when relevant.
What side effects or follow-up issues should I ask about?
Ask about stomach upset, photosensitivity, taking doxycycline with food and water, spacing it away from dairy, antacids, iron, calcium, and magnesium, and how often to reassess whether doxyPEP is still useful.